Nevirapine

Last Updated: 04/28/2026

Need to find the closest trial?
Sort By Distance
Save trials for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
2 clinical trials found

    Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission: A Phase I/II Proof of Concept Study

    Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission: A Phase I/II Proof of Concept Study

    Who is this study for: Infants infected with HIV
    Enrollment Status: Recruiting
    Publish Date: April 03, 2026
    Intervention Type: Drug
    Study Drugs: Nucleoside Reverse Transcriptase Inhibitors, Nevirapine, Lopinavir+Ritonavir, Raltegravir, VRC01
    Study Phase: Phase 1/Phase 2

    Summary: The study will explore the effects of early intensive antiretroviral therapy (ART) with or without a broadly neutralizing antibody (bNAb) on achieving HIV remission (HIV RNA below the limit of detection of the assay) among infants living with HIV.

    An Open-label, Single-arm Study to Provide Continued Access to Study Drug to Participants Who Have Completed Pediatric Clinical Studies Involving Gilead HIV Treatments

    An Open-label, Single-arm Study to Provide Continued Access to Study Drug to Participants Who Have Completed Pediatric Clinical Studies Involving Gilead HIV Treatments

    Enrollment Status: Recruiting
    Publish Date: March 16, 2026
    Intervention Type: Drug
    Study Phase: Phase 4

    Summary: The goal of this clinical study is to provide continued access to the study drug(s) to children and adolescents with human immunodeficiency virus type 1 (HIV-1) who completed their participation in an applicable parent study and to monitor for adverse events. The primary objectives of this study are as follows: * To provide continued access to the study drug received in the parent protocol or swit...

    Showing 1-2 of 2

    Last Updated: 04/28/2026